beta-lactams has been researched along with phenylalanine arginine beta-naphthylamide in 3 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (phenylalanine arginine beta-naphthylamide) | Trials (phenylalanine arginine beta-naphthylamide) | Recent Studies (post-2010) (phenylalanine arginine beta-naphthylamide) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 95 | 0 | 51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, L; Bernardini, AF; Berti, L; Bolla, JM; Lorenzi, V; Muselli, A; Pagès, JM | 1 |
| Burrows, LL; Cavallari, JF; Lamers, RP | 1 |
| Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C | 1 |
3 other study(ies) available for beta-lactams and phenylalanine arginine beta-naphthylamide
| Article | Year |
|---|---|
Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species.
Topics: Acyclic Monoterpenes; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Dipeptides; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Negative Bacteria; Helichrysum; Humans; Microbial Sensitivity Tests; Quinolones; Terpenes | 2009 |
The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
Topics: Anilino Naphthalenesulfonates; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Culture Media; Detergents; Dipeptides; Drug Resistance, Bacterial; Gram-Negative Bacteria; Magnesium; Microbial Sensitivity Tests; Periplasm; Pseudomonas aeruginosa | 2013 |
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies | 2016 |